According to the World Health Organization (WHO), the Janssen vaccine used in single doses may have advantages Due to its effectiveness, which in turn will avoid in some cases the care of clinics and hospitals because it prevents serious illnesses.
It is also an option to vaccinate populations difficult to access, living in conflict or for children under 18 years of age, according to the report released by the WHO.
– .
